EVH Evolent Health Inc - Class A

  1. Stocks
  2. Healthcare
  3. NYSE: EVH

Price (delayed)

$4.19

Market cap

$473.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.49

Enterprise value

$1.3B

?
Relative Growth: Rel. Growth: 30
Relative Strength: Rel. Strength: 36
Relative Valuation: Rel. Valuation: 39
Relative Profitability: Rel. Profitability: 6

Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers ...

Highlights
The EPS has shrunk by 181% YoY but it rose by 4.1% QoQ
The quick ratio has grown by 25% YoY but it has contracted by 6% from the previous quarter
The company's equity has shrunk by 57% YoY and by 3.3% QoQ
The debt has increased by 14% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.evolenthealth.com
Peers: NHC CPRT GHC ARMK

Key stats

What are the main financial stats of EVH

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
0.48%
1 week
-3.01%
1 month
2.2%
1 year
-54.99%
YTD
4.75%
QTD
-22.69%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$2.1B
Gross profit
$361.64M
Operating income
-$423.94M
Net income
-$504.99M
Gross margin
17.2%
Net margin
-24.1%
The gross margin has contracted by 15% from the previous quarter but it has grown by 4.9% YoY
The revenue has grown by 11% from the previous quarter but it has contracted by 4.5% YoY
The net margin has increased by 8% QoQ
The operating margin has increased by 7% from the previous quarter

Price vs fundamentals

How does EVH's price correlate with its fundamentals

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
1.23
P/S
0.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.62
The EPS has shrunk by 181% YoY but it rose by 4.1% QoQ
The company's equity has shrunk by 57% YoY and by 3.3% QoQ
EVH's price to book (P/B) is 54% lower than its 5-year quarterly average of 2.7 but 12% higher than its last 4 quarters average of 1.1
The price to sales (P/S) is 85% lower than the 5-year quarterly average of 1.5 and 27% lower than the last 4 quarters average of 0.3
The revenue has grown by 11% from the previous quarter but it has contracted by 4.5% YoY

Efficiency

How efficient is Evolent Health business performance
EVH's return on invested capital has dropped by 176% year-on-year but it is up by 6% since the previous quarter
The ROE has contracted by 20% from the previous quarter
The ROS rose by 10% QoQ

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 24% higher than its total liabilities
The quick ratio has grown by 25% YoY but it has contracted by 6% from the previous quarter
The company's current ratio rose by 23% YoY but it fell by 6% QoQ
The debt is 153% higher than the equity
EVH's debt to equity has surged by 166% year-on-year
The company's equity has shrunk by 57% YoY and by 3.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.